Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning

British Journal of Pharmacology

Volumn 126, Issue 3, 1999, Pages 701-708

  Imagawa, J ^a   Yellon, D M ^a   Baxter, G F ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Aminoguanidine; Dexamethasone; Ischaemic preconditioning; Myocardial infarction; Nitric oxide synthase; Rabbit; Second window of protection

Indexed keywords

AMINOGUANIDINE; DEXAMETHASONE; NITRIC OXIDE SYNTHASE; TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; BLOOD PRESSURE; DEXAMETHASONE; ENZYME INDUCTION; ENZYME INHIBITORS; GUANIDINES; HEART RATE; HEMODYNAMIC PROCESSES; HYDROGEN-ION CONCENTRATION; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RABBITS;

EID: 0033021520     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702368     Document Type: Article

References (52)

1. AUPHAN, N., DIDONATO, J.A., ROSETTE, C., HELMBERG, A. & KARIN, M. (1995). Immunosuppression by glucocorticoids: inhibition of NFκB activity through induction of IκB synthesis. Science, 270, 286-290.
2. BAXTER, G.F., GOMA, F.M. & YELLON, D.M. (1995). Involvement of protein kinase C in the delayed cytoprotection following sublethal ischemia in rabbit myocardium. Br. J. Pharmacol., 115, 222-224.
3. BAXTER, G.F., GOMA, F.M. & YELLON, D.M. (1997). Characterisation of the infarct-limiting effect of delayed preconditioning: timecourse and dose-dependency studies in rabbit myocardium. Basic Res. Cardiol., 92, 159-167.
4. BAXTER, G.F., GOODWIN, R.W., WRIGHT, M.J., KERAC, M., HEADS, R.J. & YELLON, D.M. (1996). Myocardial protection after monophosphoryl lipid A: studies of delayed anti-ischaemic properties in rabbit heart. Br. J. Pharmacol., 117, 1685-1692.
5. BAXTER, G.F., MARBER, M.S., PATEL, V.C. & YELLON, D.M. (1994). Adenosine receptor involvement in a delayed phase of myocardial protection 24 hours after ischemic preconditioning. Circulation, 90, 2993-3000.
6. BAXTER, G.F. & YELLON, D.M. (1998). Increased myocardial tolerance to ischaermia 24 h after adenosine A1 receptor stimulation: evidence for a role of the ATP-sensitive K+ channel. Br. J. Pharmacol., 123 (proc suppl), 94P (abstract).
7. X analog blocker of the selectin adhesion molecules, on infarct size and "no-reflow" in the rabbit model of acute myocardial infarction/reperfusion. J. Mol. Cell. Cardiol., 29, 2013-2025.
8. BOLLI, R., BHATTI, Z.A., TANG, X.-L., QIU, Y., ZHANG, Q., GUO, Y. & JADOON, A.K. (1997). Evidence that late preconditioning against myocardial stunning in conscious rabbits is triggered by the generation of nitric oxide. Circ. Res., 81, 42-52.
9. CAMERON, J.S., KIBLER, K.K.A., BERRY, H., BARRON, D.N. & SODDER, V.H. (1996). Nitric oxide activates ATP-sensitive potassium channels in hypertrophied ventricular myocytes. FASEB J., 10, A65.
10. CHATELAIN, P., LATOUR, J.G., TRAN, D., LORGERIL, M.D., DUPRAS, G. & BOURASSA, M. (1987). Neutrophil accumulation in experimental myocardial infarcts: relation with extent of injury and effect of reperfusion. Circulation, 75, 1083-1090.
11. ELLIOTT, G.T., COMERFORD, M.L., SMITH, M.L. & ZHAO, L. (1996). Myocardial ischemia/reperfusion protection using monophosphoryl lipid A is abrogated by the ATP-sensitive potassium channel blocker, glibenclamide. Cardiovasc. Res., 32, 1071- 1080.
12. EVANS, G.F. & ZUCKERMAN, S.H. (1991). Glucocorticoid-dependent and - independent mechanisms involved in lipopolysaccharide tolerance. Eur. J. Immunol., 21, 1973-1979.
13. GRIFFITHS, M.J.D., MESSENT, M., MACALLISTER, R.J. & EVANS, T.W. (1993). Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br. J. Pharmacol., 110, 963-968.
14. HALE, S.L. & KLONER, R.A. (1991). Time course of infiltration and distribution of neutrophils following coronary artery reperfusion in the rat. Cor. Art. Dis., 2, 373-378.
15. HOSHIDA, S., KUZUYA, T., FUJI, H., YAMASHITA, N., OE, H., HORI, M., SUZUKI, K., TANIGUCHI, N. & TADA, M. (1993). Sublethal ischemia alters myocardial antioxidant activity in canine heart. Am. J. Physiol., 264, H33-H39.
16. IMAGAWA, J., BAXTER, G.F. & YELLON, D.M. (1997). Genistein, a tyrosine kinase inhibitor, blocks the "second window of protection" 48 h after ischemic preconditioning in the rabbit. J. Mol. Cell. Cardiol., 29, 1885-1893.
17. IMAGAWA, J., BAXTER, G.F. & YELLON, D.M. (1998a). Delayed preconditioning against infarction may involve inducible nitric oxide synthase. Heart, 79 (suppl 1), P10.
18. IMAGAWA, J., BAXTER, G.F. & YELLON, D.M. (1998b). Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo. J. Cardiovasc. Pharmacol., 31, 74-79.
19. KIM, S.-J., GHALEH, B., KUDEJ, R.K., HUANG, C.-H., HINTZE, T.H. & VANTER, S.F. (1997). Delayed enhanced nitric oxide-mediated coronary vasodilation following brief ischemia and prolonged reperfusion in conscious dogs. Circ. Res., 81, 53-59.
20. KLEINERT, H., EUCHENHOFER, C., IHRIG-BIEDERT, I. & FORSTERMANN, U. (1996). In murine 3T3 fibroblasts, different second messenger pathways resulting in the induction of NO synthase II (iNOS) converge in the activation of transcription factor NFκB. J. Biol. Chem., 271, 6039-6044.
21. KOLIOS, G., BROWN, Z., ROBSON, R.L., ROBERTSON, D.A. & WESTWICK, J. (1995). Inducible nitric oxide synthase activity and expression in a human colonic epithelial cell line, HT-29. Br. J. Pharmacol., 116, 2866-2872.
22. KUZUYA, T., HOSHIDA, S., YAMASHITA, N., FUJI, H., OE, H., HORI, M., KAMADA, T. & TADA, M. (1993). Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ. Res., 72, 1293-1299.
23. LAPOINTE, M.C. & SITKINS, J.R. (1996). Mechanisms of interleukin- 1β regulation of nitric oxide synthase in cardiac myocytes. Hypertension, 27, 709-714.
24. LASZLO, F., EVANS, S.M. & WHITTLE, B.J.R. (1995). Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo. Eur. J. Pharmacol., 272, 169-175.
25. LEE, B.S., KANG, H.S., PYUN, K.H. & CHOI, I. (1997). Roles of tyrosine kinases in the regulation of nitric oxide synthesis in murine liver cells: modulation of NFκB activity by tyrosine kinases. Hepatol., 25, 913-919.
26. LEFER, A.M. & LEFER, D.J. (1996). The role of nitric oxide and cell adhesion molecules on the microcirculation in ischemia-reperfusion. Cardiovasc. Res., 32, 743-751.
27. LEFER, D.J., SCALIA, R., CAMPBELL, B., NOSSULI, T., HAYWARD, R., SALAMON, M., GRAYSON, J. & LEFER, A.M. (1997). Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J. Clin. Invest., 99, 684-691.
28. LUSS, H., WATKINS, S.C., FREESWICK, P.D., IMRO, A.K., NUSSLER, A.K., BILLAR, T.R., SIMMONS, R.L., DEL-NIDO, P.J. & MCGOWAN, JR, F.X. (1995). Characterization of inducible nitric oxide synthase expression in endotoxemic rat cardiac myocytes in vivo and following cytokine exposure in vitro. J. Mol. Cell. Cardiol., 27, 2015-2029.
29. MARBER, M.S., LATCHMAN, D.S., WALKER, J.M. & YELLON, D.M. (1993). Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation, 88, 1264-1272.
30. MASFERRER, J.L., SEIBERT, K., ZWEIFEL, L. & NEEDLEMAN, P. (1992). Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme. Proc. Natl. Acad. Sci. U.S.A., 89, 3917-3921.
31. MISKO, T.P., MOORE, W.M., KASTEN, T.P., NOCKOLS, G.A., CORBETT, J.A., TILTON, R.G., MCDANIEL, M.L., WILLIAMSON, J.R. & CURRIE, M.G. (1993). Selective inhibition of the inducible nitric oxide synthase by aminoguanidine. Eur. J. Pharmacol., 223, 119-125.
32. MONCADA, S. & HIGGS, A. (1993). The L-arginine-nitric oxide pathway. New Engl. J. Med., 329, 2002-2012.
33. MULLER, C.A., BAXTER, G.F., LATOUF, S.E., MCCARTHY, J., OPIE, L.H. & YELLON, D.M. (1998). Delayed preconditioning against infarction in pig heart after PTCA balloon inflations. J. Mol. Cell. Cardiol., 30, A (abstract).
34. MURPHY, M.E. & BRAYDEN, J.E. (1995). Nitric oxide hyperpolarizes rabbit mesenteric arteries via ATP-sensitive potassium channels. J. Physiol., 486, 47-58.
35. OU, P. & WOLFF, S.P. (1993). Aminoguanidine: A drug proposed for prophylaxis in diabetes inhibits catalase and generates hydrogen peroxide in vitro. Biochem. Pharmacol., 46, 1139-1144.
36. PATEL, V.C., YELLON, D.M., SINGH, K.J., NEILD, G.H. & WOOLFSON, R.G. (1993). Inhibition of nitric oxide limits infarct size in the in situ rabbit heart. Biochem. Biophys. Res. Comm., 194, 234- 238.
37. PELL, T.J., YELLON, D.M., GOODWIN, R.W. & BAXTER, G.F. (1997). Myocardial ischaemic tolerance following heat stress is abolished by ATP-sensitive potassium channel blockade. Cardiovasc. Drugs Ther., 11, 679-686.
38. QIU, Y., RIZVI, A., TANG, X.L., MANCHIKALAPUDI, S., TAKANO, H., JADOON, A.K., WU, W.-J. & BOLLI, R. (1997). Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. Am. J. Physiol., 273, H2931-H2936.
39. RADOMSKI, M.W., PALMER, R.M.J. & MONCADA, S. (1990). Glucocorticoids inhibit the expression of an inducible, but not constitutive nitric oxide synthase in vascular endothelial cells. Proc. Natl. Acad. Sci. U.S.A., 87, 10043-10047.
40. REES, D.D., CELLEK, S., PALMER, R.M.J. & MONCADA, S. (1990). Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects of vascular tone: an insight into endotoxin shock. Biochem. Biophys. Res. Comm., 173, 541-547.
41. SATRIANO, J. & ACHLONDORFF, D. (1994). Activation and attenuation of transcription factor NFκB in mouse glomerular mesangial cells in response to tumour necrosis factor-α, immunogloblin G, and adenosine 3′: 5′-cyclic monophosphate. Evidence for involvement of reactive oxygen species. J. Clin. Invest., 94, 1629-1636.
42. TAKANO, H., MANCHIKALAPUDI, S., TANG, X.-L., QUI, Y., RIZVI, A., JADOON, A.K., ZHANG, Q. & BOLLI, R. (1998). Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Circulation, 98, 441-449.
43. VEGH, A., PAPP, J.G. & PARRATT, J.R. (1994). Prevention by dexamethasone of the marked antiarrhythmic effects of preconditioning induced 20 h after rapid cardiac pacing. Br. J. Pharmacol., 113, 1081-1082.
44. WILLIAMS, M.W., TAFT, C.S., RAMNAUTH, S., ZHAO, Z.-Q. & VINTEN-JOHANSEN, J. (1995). Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit. Cardiovasc. Res., 30, 79-86.
45. WU, S., FURMAN, B.L. & PARRATT, J.R. (1996). Delayed protection against ischaemia-induced ventricular arrhythmias and infarct size limitation by the prior administration of Escherichia Coli endotoxin. Br. J. Pharmacol., 118, 2157-2163.
46. XIE, Q.W., KASHIWABARA, Y. & NATHAN, C. (1994). Role of transcription factor NFκB/Rel in induction of nitric oxide synthase. J. Biol. Chem., 269, 4705-4708.
47. YAMASHITA, N., NOSHIDA, S., TANIGUCHI, N., KUZUYA, T. & HORI, M. (1998). A 'second window of protection' occurs 24 hours after ischemic preconditioning in rat heart. J. Mol. Cell. Cardiol., 30, 1181-1189.
48. YAMASHITA, N., NISHIDA, S., HOSHIDA, S., KUZUYA, T., HORI, M., TANIGUCHI, N., KAMADA, T. & TADA, M. (1994). Induction of manganese superoxide dismutase in rat cardiac myocytes increases tolerance to hypoxia 24 hours after preconditioning. J. Clin. Invest., 94, 2193-2199.
49. YELLON, D.M. & BAXTER, G.F. (1995). A "second window of protection" or delayed preconditioning phenomenon: future horizons for myocardial protection? J. Mol. Cell. Cardiol., 27, 1023-1034.
50. YELLON, D.M., BAXTER, G.F., GARCIA-DORADO, D., HEUSCH, G. & SUMERAY, M.S. (1998). Ischaemic preconditioning: present position and future directions. Cardiovasc. Res., 37, 21-33.
51. ZHAO, L., WEBER, P.A., SMITH, J.R., COMERFORD, M.L. & ELLIOTT, G.T. (1997). Role of inducible nitric oxide synthase in pharmacological "preconditioning" with monophosphoryl lipid A. J. Mol. Cell. Cardiol., 29, 1567-1576.
52. ZHOU, X., ZHAI, X. & ASHRAF, M. (1996). Direct evidence that initial oxidative stress triggered by preconditioning contributes to second window of protection by endogenous antioxidant enzyme in myocytes. Circulation, 93, 1177-1184.